Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1740353rdf:typepubmed:Citationlld:pubmed
pubmed-article:1740353lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C0070410lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:1740353lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:1740353pubmed:issue2lld:pubmed
pubmed-article:1740353pubmed:dateCreated1992-3-23lld:pubmed
pubmed-article:1740353pubmed:abstractTextImmunization of C57BL/6 mice with syngeneic tumor cells, MBL-2, resulted in the generation of antitumor effector cells in vivo. The immunized C57BL/6 mice permanently rejected viable MBL-2 lymphoma cells, but not B16 melanoma cells. Cytotoxic T cells obtained from MBL-2-immunized mouse peritoneal cells (PEC) showed specific cytotoxicity against MBL-2, but not to YAC-1, RDM-4 and Meth A cells. By sorting with FACStar, the specific CTL were characterized as TCR alpha beta+ CD8+ T cells. Moreover, the cytoplasm of in vivo-induced CTL was stained with a monoclonal antibody against perforin. The localization of perforin in cytoplasmic granules of CTL was demonstrated by electron microscope analysis. This experiment presented the first evidence that in vivo-induced CD8+ CTL against syngeneic tumor cells expressed significant amounts of perforin.lld:pubmed
pubmed-article:1740353pubmed:languageenglld:pubmed
pubmed-article:1740353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:citationSubsetIMlld:pubmed
pubmed-article:1740353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1740353pubmed:statusMEDLINElld:pubmed
pubmed-article:1740353pubmed:monthFeblld:pubmed
pubmed-article:1740353pubmed:issn0165-2478lld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:WatanabeKKlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:TakeuchiYYlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:NishimuraTTlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:OkumuraKKlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:WanF KFKlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:HabuSSlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:AkatsukaAAlld:pubmed
pubmed-article:1740353pubmed:authorpubmed-author:ShinkaiYYlld:pubmed
pubmed-article:1740353pubmed:issnTypePrintlld:pubmed
pubmed-article:1740353pubmed:volume31lld:pubmed
pubmed-article:1740353pubmed:ownerNLMlld:pubmed
pubmed-article:1740353pubmed:authorsCompleteYlld:pubmed
pubmed-article:1740353pubmed:pagination183-7lld:pubmed
pubmed-article:1740353pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:meshHeadingpubmed-meshheading:1740353-...lld:pubmed
pubmed-article:1740353pubmed:year1992lld:pubmed
pubmed-article:1740353pubmed:articleTitlePerforin is expressed in CTL populations generated in vivo.lld:pubmed
pubmed-article:1740353pubmed:affiliationDepartment of Immunology, Tokai University School of Medicine, Isehara, Japan.lld:pubmed
pubmed-article:1740353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1740353pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1740353lld:pubmed